FLT3 and acute myeloid leukemia: The cell lines with mutated FLT3 were derived from patients with various AML subtype diagnoses and have additional genetic abnormalities that also contribute to their pathogenicity but do not appear to alter their sensitivity to inhibitors of FLT3.